Craft Winning Strategies for Cash-Strapped Biotech Funding

Biotech funding: Raising money in a cash-strapped, depleted industry can be a daunting task.  If you want your best shot at raising the necessary cash for your program, you need to think strategically. A solid regulatory and clinical development strategy will be well worth the effort.  

First up is developing your target product profile. In completing this exercise, you can begin to assess your value and potential impact.  What can your assets accomplish?  Which indications have the most attractive market opportunities?  While those are relevant considerations, they are not the only considerations. 

The key to this exercise is to review competitor product reference labels from target regions of interest. This will aid in understanding what regulators have accepted, what they have not, and what may be a potential differentiator for your product. Also, part of this exercise is to understand the competitive environment for final marketing and the requisite clinical trials to get there.  It’s important to remember that you don’t want to evaluate the competitive space as it is now…where will it be by the time you get into the clinic or the market?  These considerations may ultimately lead to changing your target profile altogether.   

Biotech Funding

The power of this exercise is that it provides a solid goalpost and keeps the program on task. While there is never a guarantee for success, this type of careful assessment will help you be able to predict your decisions to keep moving forward or stop before too many resources have been burned.  

This type of information is also essential when raising funding. Investors don’t just want to see that you have positive results in animals; they want to understand how those results will translate to the patient and what impact the therapy can have on the market.  

At OncoBay Clinical, the leading global oncology CRO, we can empower your success in the competitive landscape. Our expertise enables you to craft a compelling investment narrative, ensuring your clinical development strategy aligns with regulatory expectations, market opportunities, and competitive dynamics. We provide comprehensive support, from developing your target product label profile to assessing the competitive environment, ensuring your program is on track for success. With OncoBay Clinical, you gain the insights and guidance needed to translate promising research into impactful therapies, attracting investors, and advancing your oncology program toward the market – partner with us to unlock your full potential and make a meaningful difference in the fight against cancer. 

Want to learn more about our services to support Biotech Funding? Contact us.
We are looking forward to hearing from you.

Take Advantage of OncoBay’s Innovative Approach


Submit a Request for Proposal

Submit Proposal

OncoBay is now Kapadi


Once three entities – OncoBay Clinical, Clinscience, and Exom Group s.r.l – now we stand as one, bringing forth a symphony of expertise and seamless operations. To celebrate our unity, we re-brand under the banner of Kapadi, and embark on a new chapter of exceptional service in oncology clinical research.

Kapadi is not just a name; it's a testament to our fusion. It signifies the our standing as a global CRO powerhouse committed to accelerating groundbreaking cancer therapies that uplift patients worldwide. From conceptualizing studies, navigating regulations, and analyzing data, we provide a comprehensive array of services designed to empower your oncology clinical trials.




This pop-up will auto-close in 10 seconds.

This will close in 5 seconds